GILD vs KLIC · P/E 18, rev $7.80B vs P/E 99, rev $654.1M
Gilead Sciences Inc (GILD) versus Kulicke and Soffa Industries Inc (KLIC) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Kulicke and Soffa Industries Inc (KLIC) is a semiconductor equipment & materials company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported KLIC revenue for 2025-10-04 was $654.1M. Net income was $213.0K. KLIC currently screens at market cap $1.94B and trailing P/E 99.4.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. KLIC currently screens at market cap $1.94B and trailing P/E 99.4.
Not investment advice. Open the GILD and KLIC stock pages for the full models.
Not investment advice.